Ronald Anderson, MD, FRCPC

Alberta's Children's Hospital
2888 Shaganappi Trail NW
Calgary, AB
CAN T3B 6A8
Papers:
2725 Targeting Oncogenic Polyamines in Refractory Pediatric Leukemias Using the Anti-Protozoan Drug Α-Difluoromethylornithine (DFMO) in Combination with GC7 and Aurothioglucose